Zoetis | ZTS - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
AbbVie USD 12.54B 474M 2026-03
Align Technology USD 736.59M 53M 2026-03
Bayer EUR 6.94B 1.58B 2025-12
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Charles River Laboratories USD 279.32M 7.36M 2026-03
Coherus Biosciences USD 8.7M 853K 2025-12
Dentsply International USD 427M 16M 2026-03
Eli Lilly USD 15.92B 1.33B 2025-12
Henry Schein USD 1.07B 7M 2026-03
Idexx Laboratories USD 722.74M 64.62M 2026-03
Illumina USD 721M 38M 2026-03
IQVIA Holdings USD 1.07B 52M 2026-03
J&J USD 17.24B 642M 2026-03
Laboratory Of America USD 1.01B 20.6M 2026-03
Merck USD 10.85B 2.57B 2025-12
Neogen USD 99M 7.7M 2025-12
Pacira USD 126.64M 15.61M 2026-03
Perrigo USD 325.5M 36.7M 2026-03
Pfizer USD 11.04B 1.24B 2026-03
Phibro Animal Health USD 133.5M 12.6M 2025-12
Quest Diagnostics USD 906M 33M 2026-03
Sanofi EUR 8.45B 1.31B 2025-12
Sanofi EUR 8.11B 343M 2026-03
Zoetis USD 1.62B 20M 2026-03